LLY

911.65

+0.96%↑

JNJ

235.8

+0.14%↑

ABBV

205.01

+0.38%↑

NVS

147.58

+1.16%↑

AZN

184.25

+0.48%↑

LLY

911.65

+0.96%↑

JNJ

235.8

+0.14%↑

ABBV

205.01

+0.38%↑

NVS

147.58

+1.16%↑

AZN

184.25

+0.48%↑

LLY

911.65

+0.96%↑

JNJ

235.8

+0.14%↑

ABBV

205.01

+0.38%↑

NVS

147.58

+1.16%↑

AZN

184.25

+0.48%↑

LLY

911.65

+0.96%↑

JNJ

235.8

+0.14%↑

ABBV

205.01

+0.38%↑

NVS

147.58

+1.16%↑

AZN

184.25

+0.48%↑

LLY

911.65

+0.96%↑

JNJ

235.8

+0.14%↑

ABBV

205.01

+0.38%↑

NVS

147.58

+1.16%↑

AZN

184.25

+0.48%↑

Search

Omnicell Inc

Cerrado

SectorSanidad

34.17 3.36

Resumen

Variación precio

24h

Actual

Mínimo

32.66

Máximo

34.56

Métricas clave

By Trading Economics

Ingresos

-7.5M

-2M

Ventas

3.4M

314M

P/B

Media del Sector

857.25

57.833

BPA

0.51

Margen de beneficios

-0.645

Empleados

3,580

EBITDA

-9.8M

21M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+75.88% upside

Dividendos

By Dow Jones

Próximas Ganancias

5 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-679M

1.6B

Apertura anterior

30.81

Cierre anterior

34.17

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

147 / 350 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Omnicell Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

22 mar 2026, 23:50 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

22 mar 2026, 23:50 UTC

Charlas de Mercado

LG Electronics Set to Stage Strong Earnings Rebound in 1Q -- Market Talk

22 mar 2026, 23:49 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Lower on Prospects of Liquidity-Driven Sales -- Market Talk

22 mar 2026, 23:49 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Nikkei May Fall as Concerns About Middle East Conflict Persist -- Market Talk

22 mar 2026, 23:49 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Global Forex and Fixed Income Roundup: Market Talk

22 mar 2026, 23:41 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Oil Edges Lower as Traders Eye Trump's Deadline to Reopen Strait of Hormuz -- Market Talk

22 mar 2026, 22:57 UTC

Adquisiciones, fusiones, absorciones

Perseus Mining: Location of Aurum's Discoveries Present Potential Future Synergies

22 mar 2026, 22:56 UTC

Adquisiciones, fusiones, absorciones

Perseus Mining: Aurum Share Acquisition Cost A$23.69 Million

22 mar 2026, 22:56 UTC

Adquisiciones, fusiones, absorciones

Perseus Mining: Aurum's Boundiali Gold Project Located to South of Sissingue Gold Mine

22 mar 2026, 22:55 UTC

Adquisiciones, fusiones, absorciones

Perseus Mining: Participated in Aurum Resources Equity Raising

22 mar 2026, 22:54 UTC

Adquisiciones, fusiones, absorciones

Perseus Mining: Acquires 9.9% Interest in Aurum Resources

22 mar 2026, 22:22 UTC

Charlas de Mercado
Noticias de Eventos Importantes

After Selloff, Gold Seen Supported by Strait of Hormuz Deadline -- Market Talk

22 mar 2026, 22:06 UTC

Adquisiciones, fusiones, absorciones

Synopsys Has Market Value Over $80 Billion; Major Customers Include Nvidia -- WSJ

22 mar 2026, 22:06 UTC

Adquisiciones, fusiones, absorciones

Activist Elliott Builds Big Stake in Chip-Design Software Maker Synopsys -- WSJ

22 mar 2026, 22:06 UTC

Adquisiciones, fusiones, absorciones

Activist Elliott Investment Management Has Multibillion-Dollar Investment in Synopsys, Sources Say -- WSJ

22 mar 2026, 22:06 UTC

Adquisiciones, fusiones, absorciones

Elliott Plans to Push Synopsys to Make More Money From Its Software and Services, Sources Say -- WSJ

22 mar 2026, 21:53 UTC

Ganancias

Zijin Gold International Plans 59.2 Tons of Gold Production in 2026; up 12.3% on Year >2259.HK

22 mar 2026, 21:53 UTC

Ganancias

Zijin Gold International Rising Gold Prices Supported Results >2259.HK

22 mar 2026, 21:53 UTC

Ganancias

Zijin Gold International 2025 Rev $5.38B Vs. $2.99B >2259.HK

22 mar 2026, 21:53 UTC

Ganancias

Zijin Gold International 2025 Net $1.60B Vs. Net $481.37M >2259.HK

22 mar 2026, 21:31 UTC

Ganancias

China Petroleum & Chemical Plans CNY131.6B-CNY148.6B Capex Spending in 2026>0386.HK

22 mar 2026, 21:31 UTC

Ganancias

China Petroleum & Chemical: Decrease in Sales Volumes of Refined Oil Products Also Hurt Results >0386.HK

22 mar 2026, 21:31 UTC

Ganancias

China Petroleum & Chemical 2025 Results Weighed by Decrease in Prices of Petroleum, Petrochemical Products>0386.HK

22 mar 2026, 21:31 UTC

Ganancias

China Petroleum & Chemical 2025 Rev CNY2.78T Vs. CNY3.07T >0386.HK

22 mar 2026, 21:31 UTC

Ganancias

China Petroleum & Chemical 2025 Net CNY32.48B Vs. Net CNY48.94B >0386.HK

22 mar 2026, 21:25 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Bonds Decoupling From Oil Amid Longer Conflict Fears -- Market Talk

22 mar 2026, 21:22 UTC

Adquisiciones, fusiones, absorciones

St Barbara: Remarks Follow Recent Inquiries About Simberi's Fuel Stocks

22 mar 2026, 21:21 UTC

Adquisiciones, fusiones, absorciones

St Barbara: Simberi Currently Uses About 65,000 Liters Per Day For Mining Fleet, Power Generation

22 mar 2026, 21:21 UTC

Charlas de Mercado

Revised Fuel Subsidy Mechanism Positive for Ampol, Viva Energy -- Market Talk

22 mar 2026, 21:21 UTC

Adquisiciones, fusiones, absorciones

St Barbara: Has Been Taking Precaution to Increase Diesel Storage For Several Months

Comparación entre iguales

Cambio de precio

Omnicell Inc previsión

Precio Objetivo

By TipRanks

75.88% repunte

Estimación a 12 Meses

Media 58.2 USD  75.88%

Máximo 70 USD

Mínimo 49 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Omnicell Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

7 ratings

6

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

24.23 / 30.44Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

147 / 350 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat